Download This Paper
Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6
27 Pages Posted: 7 May 2020
More...Abstract
Background: The immune response to SARS-CoV-2 is essential for control and resolution of infection, but when dysregulated it may cause immunopathology. Inflammatory cytokine storm in severe cases of novel coronavirus disease (COVID-19) is associated with extensive lung tissue damage that may rapidly evolve towards severe respiratory failure. Laboratory hallmarks in COVID-19 patients are decreased white cell blood counts, lymphocytopenia, increased D-dimer and C reactive protein (CRP). The aim of our study was to evaluate the usefulness of testing serum IL-6, alone and together with other serological and clinical biomarkers, to predict short-term negative clinical course of COVID-19 patients admitted to a non critical hospital setting.
Methods: This is an observational retrospective study including 208 patients with COVID-19, classified as moderate (n=91, 43.8%) or severe (n=117, 56.2%), with no immediate need of ventilatory assistance. Clinical and laboratory findings were reviewed and analysed by using survival analysis and logistic regression modelling with a LASSO procedure for variable selection. In particular, we used 3-day worsening as an outcome in a logistic model to generate a prognostic score.
Findings: In our case series, 131/208 patients (62.9%) displayed abnormal IL-6 serum level (>10 pg/ml) (mean value ± SD: 27±40.9). Clinical worsening including death (n=16) and the need for non-invasive mechanical ventilation or ICU (n=46) occurred in 62 patients, of whom 45 worsened within 3 days after admission. The risk of clinical worsening was progressively enhanced along with increasing quartiles of IL-6 levels at admission [Hazard Ratio (HR): 8.2, 95%CI: 2.5 – 27.3 for the highest vs. lowest quartile]. Although IL-6 moderately correlated with other parameters, the multivariate logistic model showed that IL-6 (p=0.002), SaO2/FiO2 ratio (p<0.001) and CRP (p=0.014) were the best predictors for clinical deterioration in the first 3 days after admission. The combined score yielded an AUC=0.887 (95%CI 0.838 – 0.935) and also showed good performance to predict 2-day (AUC=0.885), 4-day (AUC=0.873) and 7-day worsening (AUC= 0.857). Finally, a nomogram predicting the probability of 3-day worsening was generated.
Interpretation: Combining clinical and laboratory findings (SaO2/FiO2 ratio, IL-6 and CRP) upon admission may be useful in the early identification of moderate-to-severe COVID-19 patients at high risk for further clinical deterioration.
Funding Statement: None.
Declaration of Interests: All the Authors declare no competing interests.
Ethics Approval Statement: The procedures followed in the study were approved by the Local Ethical Committee (protocol 16859).
Keywords: COVID-19; IL-6; Cytokine Storm; Sars-Cov2; Predictive Factors
Suggested Citation: Suggested Citation